CA2820445A1 - Methods for treating dental diseases, disorders, and injuries - Google Patents

Methods for treating dental diseases, disorders, and injuries Download PDF

Info

Publication number
CA2820445A1
CA2820445A1 CA2820445A CA2820445A CA2820445A1 CA 2820445 A1 CA2820445 A1 CA 2820445A1 CA 2820445 A CA2820445 A CA 2820445A CA 2820445 A CA2820445 A CA 2820445A CA 2820445 A1 CA2820445 A1 CA 2820445A1
Authority
CA
Canada
Prior art keywords
cells
accs
cell
timp
derived therefrom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2820445A
Other languages
English (en)
French (fr)
Inventor
William J. Golden
Randal G. Rupp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stemnion LLC
Original Assignee
Stemnion LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemnion LLC filed Critical Stemnion LLC
Publication of CA2820445A1 publication Critical patent/CA2820445A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C17/00—Devices for cleaning, polishing, rinsing or drying teeth, teeth cavities or prostheses; Saliva removers; Dental appliances for receiving spittle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Dentistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA2820445A 2010-12-20 2011-12-14 Methods for treating dental diseases, disorders, and injuries Abandoned CA2820445A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061459859P 2010-12-20 2010-12-20
US61/459,859 2010-12-20
PCT/US2011/001980 WO2012087348A1 (en) 2010-12-20 2011-12-14 Methods for treating dental diseases, disorders and injuries

Publications (1)

Publication Number Publication Date
CA2820445A1 true CA2820445A1 (en) 2012-06-28

Family

ID=46234868

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2820445A Abandoned CA2820445A1 (en) 2010-12-20 2011-12-14 Methods for treating dental diseases, disorders, and injuries

Country Status (6)

Country Link
US (2) US20130302262A1 (enExample)
EP (1) EP2654434A4 (enExample)
JP (1) JP5906252B2 (enExample)
CN (1) CN103338643B (enExample)
CA (1) CA2820445A1 (enExample)
WO (1) WO2012087348A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9802010B2 (en) * 2013-11-22 2017-10-31 Noveome Biotherapeutics, Inc. Interproximal drug delivery device
US20150335712A1 (en) 2014-05-21 2015-11-26 Stemnion, Inc. Treatment of Diseases and Conditions Caused by Increased Vascular Permeability
CA3026021A1 (en) * 2016-08-16 2018-02-22 Credentis Ag Composition comprising self-assembling peptides for use in treatment of gingivitis, periodontitis and/or peri-implantitis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001249329A1 (en) 2000-03-20 2001-10-03 Brigham And Women's Hospital Lipoxin analogs and methods for the treatment of periodontal disease
WO2003089619A2 (en) * 2002-04-19 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Placental derived stem cells and uses thereof
EP1755537A4 (en) 2004-04-14 2009-12-09 Univ Boston METHOD AND COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTOPATHIA
US20080045575A1 (en) 2004-12-29 2008-02-21 Van Dyke Thomas E Delivery of H2 Antagonists
US8153430B2 (en) 2005-03-31 2012-04-10 Stemnion, Inc. Methods related to surgery
US20060222634A1 (en) 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
US8636986B2 (en) 2005-11-18 2014-01-28 The Forsyth Institute Treatment and prevention of bone loss using resolvins
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
JP2008206500A (ja) * 2007-02-28 2008-09-11 Tokyo Univ Of Science 歯の製造方法及びこれにより得られた歯
EP2173310A4 (en) 2007-07-24 2011-10-26 Stemnion Inc METHODS FOR PROMOTING HAIR GROWTH
CN104623669A (zh) * 2007-08-22 2015-05-20 斯丹姆涅恩有限公司 含细胞因子溶液的新组合物
CA2736663C (en) * 2007-09-07 2018-01-02 Surgical Biologics, Llc. Placental tissue grafts and improved methods of preparing and using the same
JP6093714B2 (ja) * 2011-01-18 2017-03-08 ステムニオン，インコーポレイテッド 創傷治癒デバイスおよび方法
AU2012217975B2 (en) * 2011-02-14 2015-11-19 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same

Also Published As

Publication number Publication date
US20120156649A1 (en) 2012-06-21
EP2654434A4 (en) 2015-11-04
CN103338643B (zh) 2016-02-10
JP2014501242A (ja) 2014-01-20
US20130302262A1 (en) 2013-11-14
EP2654434A1 (en) 2013-10-30
JP5906252B2 (ja) 2016-04-20
CN103338643A (zh) 2013-10-02
US8444417B2 (en) 2013-05-21
WO2012087348A1 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
US8318672B2 (en) Cellular factor-containing solution compositions
US8808753B2 (en) Methods for treating pustular psoriasis
JP2021104360A (ja) ヒト胎盤コラーゲン組成物、並びにそれらの製造方法及び使用方法
US20130172252A1 (en) Methods for promoting hair growth
US8444417B2 (en) Methods for treating dental diseases, disorders, and injuries
US20170202919A1 (en) Methods for preventing or treating optic neuritis
US9351914B2 (en) Methods for modulating hair growth using truncated laminin-511
US20160175365A1 (en) Methods for treating PKU
US20160324928A1 (en) Methods for treating blepharitis
US8883136B2 (en) Methods for accelerating the healing of connective tissues injuries and disorders
US20220030851A1 (en) Modulating ischemic injury
US8454957B2 (en) Methods for treating coagulation disorders
US20120121547A1 (en) Methods and compositions for treating chronic wounds
US8980251B2 (en) Methods for preventing and treating hemorrhoids
US9186379B2 (en) Methods for preventing or treating necrotizing enterocolitis
US20140271910A1 (en) Methods for treating urushiol-induced contact dermatitis
US20110311514A1 (en) Methods for treating disorders of amino acid metabolism

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20161109

FZDE Discontinued

Effective date: 20190702